Back to search

Peptide record

TPDB03524

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03524
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP Peptipedia Antifungipept
standard
No
A 37-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
VGRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG
Physicochemical Analysis
C196H345N63O40S1
ANDEQHMY
K
4256.35
12.72
13
0
13
+13
6.97
-0.335
107.84
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
5500
129.22
3
Residue Composition
number
0
A
6
R
0
N
0
D
1
C
0
E
0
Q
5
G
0
H
4
I
4
L
7
K
0
M
1
F
3
P
1
S
1
T
1
W
0
Y
3
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 0 C: 1 E: 0 Q: 0 G: 5 H: 0 I: 4 L: 4 K: 7 M: 0 F: 1 P: 3 S: 1 T: 1 W: 1 Y: 0 V: 3
Chemical Descriptors
37
C196H345N63O40S1
4256.35
12.72
+13
6.97
-0.335
Evidence Records 28 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

S. typhimurium

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or
Evidence 2 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria
Evidence 3 Activity

Activity

MIC
Antibacterial
0.6 µM

Target

A. Baumannii

Source & Reference

dbAMP

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRS
Evidence 4 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

Pseudomonas aeruginosa ATCC 27853 or PAO1

Source & Reference

dbAMP

Other

S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and
Evidence 5 Activity

Activity

MIC
Antibacterial
20 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie
Evidence 6 Activity

Activity

MIC
Antibacterial
1.25 µM

Target

B. Globigii

Source & Reference

dbAMP

Other

TCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarde
Evidence 7 Activity

Activity

MIC
Antibacterial
5 µM

Target

L. Monocytogenes

Source & Reference

dbAMP

Other

Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarded DNA migration in the 0.8% agaro
Evidence 8 Activity

Activity

MIC
Antifungal
2.5 µM

Target

S. typhimurium

Source & Reference

dbAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or
Evidence 9 Activity

Activity

MIC
Antifungal
2.5 µM

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP Antifungipept

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria
Evidence 10 Activity

Activity

MIC
Antifungal
0.6 µM

Target

A. Baumannii

Source & Reference

dbAMP Antifungipept

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRS
Evidence 11 Activity

Activity

MIC
Antifungal
2.5 µM

Target

Pseudomonas aeruginosa ATCC 27853 or PAO1

Source & Reference

dbAMP Antifungipept

Other

S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and
Evidence 12 Activity

Activity

MIC
Antifungal
20 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP Antifungipept

Other

A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie
Evidence 13 Activity

Activity

MIC
Antifungal
1.25 µM

Target

B. Globigii

Source & Reference

dbAMP Antifungipept

Other

TCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarde
Evidence 14 Activity

Activity

MIC
Antifungal
5 µM

Target

L. Monocytogenes

Source & Reference

dbAMP Antifungipept

Other

Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarded DNA migration in the 0.8% agaro
Evidence 15 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

S. typhimurium

Source & Reference

NA

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or
Evidence 16 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria
Evidence 17 Activity

Activity

MIC
Antiparasitic
0.6 µM

Target

A. Baumannii

Source & Reference

NA

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRS
Evidence 18 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

Pseudomonas aeruginosa ATCC 27853 or PAO1

Source & Reference

NA

Other

S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and
Evidence 19 Activity

Activity

MIC
Antiparasitic
20 µM

Target

Staphylococcus aureus

Source & Reference

NA

Other

A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie
Evidence 20 Activity

Activity

MIC
Antiparasitic
1.25 µM

Target

B. Globigii

Source & Reference

NA

Other

TCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarde
Evidence 21 Activity

Activity

MIC
Antiparasitic
5 µM

Target

L. Monocytogenes

Source & Reference

NA

Other

Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarded DNA migration in the 0.8% agaro
Evidence 22 Activity

Activity

MIC
Antiviral
2.5 µM

Target

S. typhimurium

Source & Reference

NA

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or
Evidence 23 Activity

Activity

MIC
Antiviral
2.5 µM

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria
Evidence 24 Activity

Activity

MIC
Antiviral
0.6 µM

Target

A. Baumannii

Source & Reference

NA

Other

active against Gram- S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRS
Evidence 25 Activity

Activity

MIC
Antiviral
2.5 µM

Target

Pseudomonas aeruginosa ATCC 27853 or PAO1

Source & Reference

NA

Other

S. typhimurium (MIC 2.5 uM), E. coli ATCC 25922 (MIC 2.5 uM), A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and
Evidence 26 Activity

Activity

MIC
Antiviral
20 µM

Target

Staphylococcus aureus

Source & Reference

NA

Other

A. Baumannii (MIC 0.6 uM), P. aeruginosa ATCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie
Evidence 27 Activity

Activity

MIC
Antiviral
1.25 µM

Target

B. Globigii

Source & Reference

NA

Other

TCC 27853 or PAO1 (MIC 2.5 uM), Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarde
Evidence 28 Activity

Activity

MIC
Antiviral
5 µM

Target

L. Monocytogenes

Source & Reference

NA

Other

Gram+ bacteria S. aureus (MIC 20 uM), MRSA (MIC > 40 uM), B. Globigii (MIC 1.25 uM), and L. Monocytogenes (MIC 5 uM) ( Pashaie et al., 2025 ). In vitro, this peptide retarded DNA migration in the 0.8% agaro